Nearly a decade of research and development were invested
The Transaction is expected to close in the fourth quarter of 2021
“We are excited to partner with Curaleaf to create an exceptional showcase"
“We look forward to completing the remaining steps required"
The MRA removed the eligibility restriction for 5 license types
The Transaction is valued at approximately US$39.0 million
Aphria and Tilray are together at last
"We're thrilled to be recognized in such prestigious rankings"
"We are very pleased with the strong investor interest"
“Reaching 100 dispensaries nationwide is a remarkable milestone"